Orion - Annual Financial Report

Orion Group Financial Statement documents 2015 and Corporate Governance Statement published

ORION CORPORATION      STOCK EXCHANGE RELEASE 29 FEBRUARY 2016 at 10.00 a.m.
EET


Orion Group Financial Statement documents 2015 and Corporate Governance
Statement published

Orion Group's Financial Statement documents for 2015 have been published. The
documents are available in Finnish and English on the Company's website at
http://www.orion.fi/en.

The official financial statement documents, which include the financial
statements, the report of the Board of Directors and the auditor's report are
available in Finnish at http://www.orion.fi/yhtiokokous2016.

Orion's Corporate Governance Statement for year 2015, adopted by the Board of
Directors, is published as a separate report in Finnish and English on the
Company's website at http://www.orion.fi/en.





Orion Corporation



 Olli Huotari               Terhi Ormio
 SVP, Corporate Functions   VP, Communications




Contact person:
Tuukka Hirvonen, Communications Manager, IR & Financial Communications
tel. +358 10 426 2721


Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. The core therapy areas of Orion's pharmaceutical R&D are
central nervous system (CNS) disorders, oncology and respiratory for which Orion
developes inhaled Easyhaler® pulmonary drugs.

Orion's net sales in 2015 amounted to EUR 1,016 million and the company had
about 3,400 employees. Orion's A and B shares are listed on Nasdaq Helsinki.

[HUG#1990041]

Attachments:

Orion Corporate Governance Statement 2015.pdf

Orion Financial Statement documents 2015.pdf